Premier Asset Management LLC Revance Therapeutics, Inc. Transaction History

Premier Asset Management LLC

  • $0
  • Q1 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$24.03 - $29.97 $338,630 - $422,337
-14,092 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$23.41 - $28.34 $77,276 - $93,550
3,301 Added 30.59%
14,092 $399,000
Q3 2020

Nov 16, 2020
BUY
$23.23 - $34.3 $250,674 - $370,131
10,791 New
10,791 $272,000
Q3 2019

Nov 01, 2019
SELL
$10.22 - $14.5 $231,145 - $327,946
-22,617 Closed
0 $0
Q2 2019

Aug 07, 2019
BUY
$10.67 - $15.49 $241,323 - $350,337
22,617 New
22,617 $293,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email